New shot could bring relief to teens with severe eczema
NCT ID NCT07042126
First seen Nov 18, 2025 · Last updated May 14, 2026 · Updated 28 times
Summary
This study tests a new medicine called 611 in Chinese teenagers (ages 12-17) with moderate-to-severe atopic dermatitis (eczema). The drug targets a protein involved in inflammation to reduce skin redness, itching, and rashes. About 180 participants will receive either 611 or a placebo, and doctors will check if their skin improves significantly after 16 weeks. The goal is to see if 611 can safely control eczema symptoms better than a dummy treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
RECRUITINGNanchang, Zhejiang, 310003, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Fourth Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGJinhua, Zhejiang, 322000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.